Concepedia

Yuqing Mao

YM

Statistics

Publications

37

Citations

2.1K

H-Index

28

Active since

2013

Affiliations

Jinshan Hospital of Fudan University(Current)

Tongji University

Shanghai Tenth People's Hospital

Shanghai First People's Hospital

Fudan University

Yuqing Mao is an author at Jinshan Hospital of Fudan University specializing in life sciences, pharmacology, and liver disease.

ORCID

Publications per year

2013–2024

37

Publications

37

Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis

Jiao Feng, Weiqi Dai, Yuqing Mao et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 231 citations · Full text

, , +17

Quercetin shows anti‐tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway

Liwei Wu, Jingjing Li, Tong Liu et al. · Cancer Medicine · 2019 · 186 citations · Full text

, , +14

Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA

Fujun Yu, Jianjian Zheng, Yuqing Mao et al. · Journal of Biological Chemistry · 2015 · 147 citations · Full text

, , +6

Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non‐alcoholic fatty liver disease by up‐regulating the FGF21/PGC‐1α pathway

Liwei Wu, Wenhui Mo, Jiao Feng et al. · British Journal of Pharmacology · 2020 · 144 citations · Full text

, , +17

PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma

Jiao Feng, Liwei Wu, Jie Ji et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 108 citations · Full text

, , +17

1–5 of 37